Clinical Trials Directory

Trials / Unknown

UnknownNCT02576418

PartoSure to Predict Spontaneous Preterm Delivery in Pregnancies After Assisted Reproductive Technology (ART)

Evaluation of the PartoSure Time to Delivery (TTD) Test to Predict Spontaneous Preterm Delivery in Pregnancies After Assisted Reproductive Technology (ART)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Vietnam National University · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

To calculate sensitivity (SN), specificity (SP), positive predictive value (PPV) and negative predictive value (NPV) of PartoSure TTD test in predicting delivery within 7 or 14 days from testing and to compare it with cervical length (CL) measurement by transvaginal ultrasound (15 mm cut-off)

Detailed description

* This trial is a prospective observational study. * Pregnancies after ART between 20 0/7 and 36 6/7 weeks with symptoms of preterm labor, clinically intact membranes, cervical dilatation of ≤ 2 cm will be invited to participate to the study. Signed consent form is required to be able to participate to the study. * PartoSure and CL will be performed on all patients and the test-to-spontaneous-delivery interval will be calculated. * Trial Population:Pregnancies after ART between 20 0/7 and 36 6/7 weeks with symptoms of preterm labor are hospitalized at My Duc hospital from October 2015 to April 2016. The sample size for this trial of 100 subjects.

Conditions

Interventions

TypeNameDescription
OTHERPartosure TTD testPartoSure TTD test and CL will be performed on all patients and the test-to-spontaneous-delivery interval will be calculated.

Timeline

Start date
2015-10-01
Primary completion
2017-12-01
Completion
2017-12-01
First posted
2015-10-15
Last updated
2017-09-11

Locations

1 site across 1 country: Vietnam

Source: ClinicalTrials.gov record NCT02576418. Inclusion in this directory is not an endorsement.